|
The step after "the biochemistry basically works so far as we can tell" is mouse trials. So assume five years if you're starting with old mice to see how much of an effect mitoSENS therapies have.
In terms of funding, very helpful. Anything that can be demonstrated as progress with practical application is useful.
As to medical interventions for humans: the FDA won't allow any intervention targeted at aging, so whatever development happens under regulatory oversight will be for mitochondrial diseases and narrow applications of the technology only.
If you want to see actual application to aging on a timeframe of a decade after the mouse studies are showing promise, you'll most likely want to see responsible groups in Asia or other less overregulated areas practicing the medicine and gathering data at the same time - but based on what's been happening in the stem cell field there's usually much less gathering of data than is helpful.
[Posted by: Reason at April 14, 2009 10:36 AM]
|